Conag, Mylen .
HRN: 19-27-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2024
CEFUROXIME 1.5GM (VIAL)
03/15/2024
03/15/2024
IVT
1.5gms
Now Then Q 8 Hrs
WBC 23.0
Waiting Final Action
Indication: Empiric Type of Infection: Febrile Neutropenia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes